In contrast, although intraperitoneal administration of FLT3L and CD40 agonist extended survival in mice bearing orthotopic pancreatic cancer compared with ablation monotherapy, the survival benefit from local administration of the hydrogel microsphere vaccine was significantly superior (Supplementary Fig. 20a–d). The gene discussed is CD40; the disease is pancreatic neoplasm.